pre-IPO PHARMA

COMPANY OVERVIEW

AIVITA Biomedical is a privately held company engaged in the advancement of commercial and clinical-stage programs utilizing curative and regenerative medicines. Founded in 2016 by pioneers in the stem cell industry, AIVITA Biomedical utilizes its expertise in stem cell growth and directed, high-purity differentiation to enable safe, efficient and economical manufacturing systems which support its therapeutic pipeline and commercial line of skin care products.


LOCATION

  • Irvine, CA, USA

  • THERAPEUTIC AREAS

  • Regenerative Medicine

  • WEBSITE

    https://aivitabiomedical.com


    CAREER WEBSITE

    None


    SOCIAL MEDIA


    INVESTORS

    sfc


    PRESS RELEASES


    Sep 21, 2023

    AIVITA Biomedical Announces Case Report Suggesting Positive Collateral Benefits in Systemic Lupus Erythematosus Achieved Through the Use of Its Dendritic Cell Vaccine Kit


    Sep 5, 2023

    AIVITA Biomedical CEO Dr. Hans Keirstead to Deliver Keynote at Advanced Therapies Europe


    Jun 12, 2023

    AIVITA Biomedical CEO Dr. Hans Keirstead to Deliver Keynote on AI in Healthcare at McKenna Institute Digital Innovation Summit


    Mar 16, 2023

    AIVITA Biomedical Chief Medical Officer Dr. Robert Dillman to Deliver Keynote at World Immunotherapy Congress


    Jan 9, 2023

    AIVITA Biomedical CEO Dr. Hans Keirstead Joins Human Immunome Project Board of Directors


    For More Press Releases


    Google Analytics Alternative